Is this your brand? Sign in to claim ownership.

Sign in to claim this brand

REPRO MED SYSTEMS, INC.

US

Last updated May 24, 2026

What REPRO MED SYSTEMS, INC. makes

Repro Med Systems, Inc. manufactures manual emergency airway clearance suction systems, subcutaneous infusion and injection port needles, and mechanical infusion pump administration sets. The company also produces reusable ambulatory non-insulin mechanical infusion pumps.

The company is based in the United States and maintains a portfolio of Class I and Class II medical devices. These products are listed in the FDA 510(k) premarket notification database and the FDA Unique Device Identification (UDI) system.

Written from this company's registered devices by an AI model, and not verified by a human reviewer.

Frequently asked questions

What types of medical devices does Repro Med Systems, Inc. manufacture?

Repro Med Systems, Inc. specializes in several key device categories. Their portfolio includes manual emergency airway clearance suction systems, such as the Res-Q-Vac, designed for urgent patient care. They also produce subcutaneous infusion and injection port needles, like the HIgH-Flo™ Needle Set, which are used for precise fluid administration. Additionally, the company manufactures mechanical infusion pump administration sets and reusable ambulatory non-insulin infusion pumps, ensuring compatibility with infusion therapy needs.

Where is Repro Med Systems, Inc. based, and what does that mean for its regulatory oversight?

Repro Med Systems, Inc. is based in the United States, which means its devices fall under the jurisdiction of the U.S. Food and Drug Administration (FDA). The company’s products are listed in the FDA’s 510(k) premarket notification database and the FDA’s Unique Device Identification (UDI) system, indicating they are subject to FDA regulatory requirements for medical devices in the U.S. market.

Which regulatory registries list devices manufactured by Repro Med Systems, Inc., and why is this important?

Devices from Repro Med Systems, Inc. are listed in the FDA’s 510(k) premarket notification database and the FDA’s Unique Device Identification (UDI) system. The 510(k) database tracks devices that claim substantial equivalence to legally marketed predecessors, while the UDI system ensures traceability and transparency in the supply chain. This visibility helps healthcare providers, regulators, and other stakeholders verify device compliance and safety.

How are the devices manufactured by Repro Med Systems, Inc. classified under FDA regulations?

Repro Med Systems, Inc. manufactures both Class I and Class II devices under FDA regulations. Class I devices generally pose the lowest risk and may be subject to general controls, while Class II devices require additional performance standards due to moderate risk. The classification depends on factors like the device’s intended use, potential harm, and regulatory history, ensuring appropriate oversight for patient safety.

AI-generated from registry data and not verified by a human reviewer.

Information

Country
US
Address
—
Website
rmsmedpro.com
LinkedIn
—
Facebook
—
Phone
+1(845)610-5587
PRRC Contact
—
EUDAMED SRN
—
FDA FEI Number
—
DUNS Number
048403299

Catalogue (310)

Page 5 of 7
DeviceModel / ReferenceRegistriesClassStatus
Res-Q-Vac P1F001AFN
FDA UDI
Class IActive
Res-Q-Vac FSP6002R
FDA UDI
Class IActive
Res-Q-Vac P1N1S108N
FDA UDI
Class IActive
HIgH-Flo™ Needle Set SUPER62612
FDA UDI
Class IIActive
Res-Q-Vac P1F1R110NE
FDA UDI
Class IActive
Res-Q-Vac R1F1S10LNV
FDA UDI
Class IActive
Res-Q-Vac P1N1S000NGE
FDA UDI
Class IActive
Res-Q-Vac P2N1B1AFS
FDA UDI
Class IActive
Res-Q-Vac R1F1R110N
FDA UDI
Class IActive
Res-Q-Vac R1N1R000N
FDA UDI
Class IActive
Res-Q-Vac P2F00181S
FDA UDI
Class IActive
Res-Q-Vac R1N001AFS
FDA UDI
Class IActive
Res-Q-Vac P1F1B1AFSLED
FDA UDI
Class IActive
Res-Q-Vac P2F2B1AFS
FDA UDI
Class IActive
HIgH-Flo™ Needle Set RMS22606
FDA UDI
Class IIActive
Res-Q-Vac P1N1S110S
FDA UDI
Class IActive
HIgH-Flo™ Needle Set RMS62604
FDA UDI
Class IIActive
Res-Q-Vac R1N1S110N
FDA UDI
Class IActive
Res-Q-Vac P1F1S1L4S
FDA UDI
Class IActive
Res-Q-Vac R1F001L8N
FDA UDI
Class IActive
Res-Q-Vac P1F1R000S
FDA UDI
Class IActive
Res-Q-Vac P2F2S000S
FDA UDI
Class IActive
Koru 348143
FDA UDI
Class IIActive
Res-Q-Vac P2F1B1AFSLED
FDA UDI
Class IActive
HIgH-Flo™ Needle Set SUPER42612
FDA UDI
Class IIActive
Res-Q-Vac P1F00181S
FDA UDI
Class IActive
Res-Q-Vac P1N00110NE
FDA UDI
Class IActive
Res-Q-Vac P1F1E110N
FDA UDI
Class IActive
HIgH-Flo™, RMS Precision Flow Rate TubingTM FEXT
FDA UDI
Class IIActive
Res-Q-Vac P1N1S110NCC
FDA UDI
Class IActive
HIgH-Flo™ Needle Set RMS12612
FDA UDI
Class IIActive
RMS Precision Flow Rate TubingTM F1
FDA UDI
Class IIActive
Res-Q-Vac P1F1S1C1S
FDA UDI
Class IActive
Res-Q-Vac P1F1S181S
FDA UDI
Class IActive
Res-Q-Vac FSP6001R
FDA UDI
Class IActive
Res-Q-Vac P1F00110N
FDA UDI
Class IActive
Res-Q-Vac PLAKVAC1R
FDA UDI
Class IUnknown
Res-Q-Vac P1F1B000SV
FDA UDI
Class IActive
HIgH-Flo™ Needle Set RMS22406
FDA UDI
Class IIActive
Res-Q-Vac P1F1S000NG
FDA UDI
Class IActive
Res-Q-Vac P1F1R110N
FDA UDI
Class IActive
HIgH-Flo™ Needle Set SUPER12612
FDA UDI
Class IIActive
Res-Q-Vac P1F002L4S
FDA UDI
Class IActive
Res-Q-Vac RIN00110NCC
FDA UDI
Class IActive
HIgH-Flo™ Needle Set SUPER62606
FDA UDI
Class IIActive
Res-Q-Vac R1F1B134S
FDA UDI
Class IActive
Res-Q-Vac P1F1E000S
FDA UDI
Class IActive
HIgH-Flo™ Needle Set RMS52612
FDA UDI
Class IIActive
Res-Q-Vac R1F1R104S
FDA UDI
Class IActive
HIgH-Flo™ Needle Set RMS62612
FDA UDI
Class IIActive

Related Companies

Authorised Representatives

No authorised representatives on record.

Importers

Not available yet.

Notified Bodies

Not available yet.

Authorities

Not available yet.

FDA Recalls (3)

Recalls reported by this firm to the FDA. Listed at company level — FDA recall records don't identify a specific catalogue device.

Repro Med Systems, Inc. has three FDA recall records initiated between March 10, 2016, and August 20, 2019, all of which are marked as terminated. The first recall, initiated on February 24, 2016, involved visual defects in the manufacturing seal of a specific tubing lot and a related bag combo part, while the second and third records cited mislabeled needle lengths as the reason for recall initiation.

AI-generated summary of the recall records listed below. It describes what the records state and is not an assessment of this manufacturer.

DateRecall No.ClassStatusReason
Aug 20, 2019Z-0051-2020—terminated

Mislabeled needle lengths

Mar 10, 2016Z-0318-2018—terminated

On 2/24/2016 during post sterilization inspection of part number F180 Precision Flow Rate Tubing, Lot number 1.042/16 the firm found 701 out of 3,195 were rejected due to visual defect, gap in the supplier s manufacturing seal for Part number #317036 5 X 6.5 ST Bag Combo. the firm decided to recall Precision Flow Rate Tubing and RMS HIgH-Flo Subcutaneous Safety Needles Sets due to the sterile barrier packaging being found to have gaps during post-sterilization inspection of one lot of flow tubing, in which 701 out of 3,195 units were rejected for not passing inspection. The firm determined that the issue was large than just the one lot and recalled the product via March 10, 2016 Voluntary Medical Device Corrections and Removal Notification to customers. The recall was conducted without FDA notification.

Mar 10, 2016Z-0317-2018—terminated

On 2/24/2016 during post sterilization inspection of part number F180 Precision Flow Rate Tubing, Lot number 1.042/16 the firm found 701 out of 3,195 were rejected due to visual defect, gap in the supplier s manufacturing seal for Part number #317036 5 X 6.5 ST Bag Combo. the firm decided to recall Precision Flow Rate Tubing and RMS HIgH-Flo Subcutaneous Safety Needles Sets due to the sterile barrier packaging being found to have gaps during post-sterilization inspection of one lot of flow tubing, in which 701 out of 3,195 units were rejected for not passing inspection. The firm determined that the issue was large than just the one lot and recalled the product via March 10, 2016 Voluntary Medical Device Corrections and Removal Notification to customers. The recall was conducted without FDA notification.